Pain in Spinal Muscular Atrophy: A Questionnaire Study
- PMID: 36819911
- PMCID: PMC9910355
- DOI: 10.1298/ptr.E10201
Pain in Spinal Muscular Atrophy: A Questionnaire Study
Abstract
Objective: This study aimed to reveal the chronic pain prevalence in spinal muscular atrophy (SMA) patients and identify the clinical characteristics of these patients with chronic pain. The pain status was also investigated in SMA patients with chronic pain.
Methods: This cross-sectional study was conducted between July 2018 and December 2018. SMA type II and type III patients in Japan were mailed a survey questionnaire. The survey items were chronic pain prevalence, clinical characteristics, and motor function. Patients with chronic pain also answered questions on various pain status parameters: pain intensity, frequency, duration, location using body map, and factors that exacerbated and relieved pain.
Results: The questionnaire recovery rate was 61.1%. Sixty-four type II (mean age 17.3 ± 11.7 years) and 22 type III (mean age 44.9 ± 21.6 years) patients were eligible for inclusion. The prevalence of chronic pain in type II and III patients was 40.6% and 40.9%, respectively. Type II patients with chronic pain were more likely to report the inability to sit without manual support than those without pain (p = 0.03). Pain intensity in SMA patients was mild, but pain usually occurred daily, for prolonged durations, most often in the neck, back, and lower extremities. Sitting and high physical activity exacerbated pain the most.
Conclusion: The percentage of patients with SMA with chronic pain was high, at above 40%. Moreover, the pain experienced by patients with SMA was low in intensity but frequent and most common in the lower extremities.
Keywords: Neuromuscular disease; Pain; Questionnaire survey; Spinal muscular atrophy.
©2022 Japanese Society of Physical Therapy.
Similar articles
-
Spinal muscular atrophy: survival pattern and functional status.Pediatrics. 2004 Nov;114(5):e548-53. doi: 10.1542/peds.2004-0668. Epub 2004 Oct 18. Pediatrics. 2004. PMID: 15492357
-
Chronic Pain in Patients with Spinal Muscular Atrophy in Switzerland: A Query to the Spinal Muscular Atrophy Registry.J Clin Med. 2024 May 9;13(10):2798. doi: 10.3390/jcm13102798. J Clin Med. 2024. PMID: 38792340 Free PMC article.
-
Pain in adolescents with spinal muscular atrophy and Duchenne and Becker muscular dystrophy.Eur J Paediatr Neurol. 2015 Sep;19(5):537-46. doi: 10.1016/j.ejpn.2015.04.005. Epub 2015 Apr 30. Eur J Paediatr Neurol. 2015. PMID: 25978940
-
Drug treatment for spinal muscular atrophy type I.Cochrane Database Syst Rev. 2019 Dec 11;12(12):CD006281. doi: 10.1002/14651858.CD006281.pub5. Cochrane Database Syst Rev. 2019. PMID: 31825542 Free PMC article.
-
Drug treatment for spinal muscular atrophy types II and III.Cochrane Database Syst Rev. 2020 Jan 6;1(1):CD006282. doi: 10.1002/14651858.CD006282.pub5. Cochrane Database Syst Rev. 2020. PMID: 32006461 Free PMC article.
Cited by
-
Pain in Children and Adolescents with Spinal Muscular Atrophy: A Longitudinal Study from a Patient Registry.Children (Basel). 2023 Nov 30;10(12):1880. doi: 10.3390/children10121880. Children (Basel). 2023. PMID: 38136082 Free PMC article.
-
Sensory dysfunction in SMA type 2 and 3 - adaptive mechanism or concomitant target of damage?Orphanet J Rare Dis. 2024 Sep 3;19(1):321. doi: 10.1186/s13023-024-03339-y. Orphanet J Rare Dis. 2024. PMID: 39227985 Free PMC article.
-
Health-related quality of life of adults with spinal muscular atrophy: insights from a nationwide patient registry in Germany.Qual Life Res. 2024 Jul;33(7):1949-1959. doi: 10.1007/s11136-024-03665-5. Epub 2024 May 16. Qual Life Res. 2024. PMID: 38753126
-
Cerebrospinal fluid metabolomics of pain in patients with spinal muscle atrophy.Pain Med. 2025 May 1;26(5):283-286. doi: 10.1093/pm/pnae129. Pain Med. 2025. PMID: 39673790 No abstract available.
-
Survey of feeding issues experienced by patients with spinal muscular atrophy type 2 in Japan.J Phys Ther Sci. 2025 Jun;37(6):270-273. doi: 10.1589/jpts.37.270. Epub 2025 Jun 1. J Phys Ther Sci. 2025. PMID: 40511310 Free PMC article.
References
-
- Lunn MR, Wang CH: Spinal muscular atrophy. Lancet. 2008; 371: 2120–2133. - PubMed
-
- Crawford TO, Pardo CA: The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis. 1996; 3: 97–110. - PubMed
-
- Ogino S, Leonard DG, et al. : Genetic risk assessment in carrier testing for spinal muscular atrophy. Am J Med Genet. 2002; 110: 301–307. - PubMed
-
- Pearn J: Classification of spinal muscular atrophies. Lancet. 1980; 315: 919–922. - PubMed
-
- Jensen MP, Abresch RT, et al. : Chronic pain in persons with neuromuscular disease. Arch Phys Med Rehabil. 2005; 86: 1155–1163. - PubMed